The vascular endothelium comprises a dynamic interface with the blood and acts as an integrator and transducer of both biomechanical (e.g. laminar shear stress) and biochemical stimuli (e.g. inflammatory cytokines). Exposure to laminar flow induces critical regulators of endothelial function, which confer potent anti-thrombotic, anti-adhesive, and anti-inflammatory properties. In contrast, exposure to inflammatory cytokines activates endothelial cells as evidenced by expression of adhesion molecules, which allows for the recruitment of leukocytes to the blood vessel wall. Genomic transcriptional profiling studies identified KLF2 as being induced by laminar flow and inhibited by the inflammatory cytokines. Overexpression of lung kruppel like factor (KLF2) potently inhibits inflammatory cytokine mediated induction of VCAM-1 and immune cell adhesion under dynamic flow. Furthermore, studies to date suggest that this occurs through inhibition of NF-kappaB a central regulator of inflammation. The studies in this proposal will (1) determine the molecular basis for KLF2's ability to inhibit VCAM-1 expression in response to inflammatory cytokines and (2) assess the role of KLF2 in vascular inflammation in vivo.
| Fisch, Sudeshna; Gray, Susan; Heymans, Stephane et al. (2007) Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 104:7074-9 |
| Lin, Zhiyong; Hamik, Anne; Jain, Rajan et al. (2006) Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation. Arterioscler Thromb Vasc Biol 26:1185-9 |
| Das, Hiranmoy; Kumar, Ajay; Lin, Zhiyong et al. (2006) Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc Natl Acad Sci U S A 103:6653-8 |
| Lin, Zhiyong; Kumar, Ajay; SenBanerjee, Sucharita et al. (2005) Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 96:e48-57 |
| Sen-Banerjee, Sucharita; Mir, Samy; Lin, Zhiyong et al. (2005) Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 112:720-6 |
| Kumar, Ajay; Lin, Zhiyong; SenBanerjee, Sucharita et al. (2005) Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-kappaB and histone deacetylases. Mol Cell Biol 25:5893-903 |
